- Home
- OLP vs AUTL Comparison
OLP vs AUTL Comparison
Compare OLP & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLP | AUTL |
|---|---|---|
| Founded | 1982 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 478.2M | 433.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | OLP | AUTL |
|---|---|---|
| Price | $20.80 | $1.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.33 |
| AVG Volume (30 Days) | 146.2K | ★ 3.9M |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | ★ 8.65% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.54 | N/A |
| Revenue | ★ $97,423,000.00 | $51,128,000.00 |
| Revenue This Year | $7.95 | $658.11 |
| Revenue Next Year | $6.06 | $91.34 |
| P/E Ratio | $13.53 | ★ N/A |
| Revenue Growth | 9.29 | ★ 406.67 |
| 52 Week Low | $19.62 | $1.11 |
| 52 Week High | $28.69 | $2.80 |
Technical Indicators
Market Signals| Indicator | OLP | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 48.55 | 60.25 |
| Support Level | $20.90 | $1.56 |
| Resistance Level | $21.66 | $1.69 |
| Average True Range (ATR) | 0.37 | 0.09 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 37.81 | 89.92 |
Price Performance
Historical ComparisonAbout OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.